O	O	0	3	Low	Low	B-NP	JJ	O	10	NMOD	O
T18	B-Entity	4	7	CD3	CD3	I-NP	NN	B-protein	4	NMOD	B-protein
O	O	7	8	+	+	B-NP	SYM	O	4	NMOD	O
T1	B-Protein	8	12	CD28	CD28	I-NP	NN	B-protein	1	NMOD	B-protein
O	O	12	13	-	-	O	HYPH	O	1	P	O
O	O	13	20	induced	induce	B-NP	VBN	O	10	NMOD	O
T2	B-Protein	21	32	interleukin	interleukin	I-NP	NN	B-protein	10	NMOD	B-protein
T2	I-Protein	32	33	-	-	O	HYPH	O	10	NMOD	O
T2	I-Protein	33	34	2	2	B-NP	CD	O	10	NMOD	O
O	O	35	45	production	production	I-NP	NN	O	11	SUB	O
O	O	46	56	correlates	correlate	B-VP	VBZ	O	0	ROOT	O
O	O	57	61	with	with	B-PP	IN	O	11	VMOD	O
O	O	62	71	decreased	decrease	B-NP	VBN	O	17	NMOD	O
O	O	72	80	reactive	reactive	I-NP	JJ	O	17	NMOD	O
O	O	81	87	oxygen	oxygen	I-NP	NN	O	17	NMOD	O
O	O	88	100	intermediate	intermediate	I-NP	JJ	O	17	NMOD	O
O	O	101	110	formation	formation	I-NP	NN	O	12	PMOD	O
O	O	111	113	in	in	B-PP	IN	O	17	NMOD	O
O	O	114	122	neonatal	neonatal	B-NP	JJ	B-cell_type	21	NMOD	B-cell_type
O	O	123	124	T	T	I-NP	NN	I-cell_type	21	NMOD	I-cell_type
O	O	125	130	cells	cell	I-NP	NNS	I-cell_type	18	PMOD	I-cell_type
O	O	130	131	.	.	O	.	O	11	P	O

O	O	133	136	The	The	B-NP	DT	O	2	NMOD	O
O	O	137	145	capacity	capacity	I-NP	NN	O	0	ROOT	O
O	O	146	148	of	of	B-PP	IN	O	2	NMOD	O
O	O	149	157	neonatal	neonatal	B-NP	JJ	B-cell_type	6	NMOD	B-cell_type
O	O	158	159	T	T	I-NP	NN	I-cell_type	6	NMOD	I-cell_type
O	O	160	165	cells	cell	I-NP	NNS	I-cell_type	3	PMOD	I-cell_type
O	O	166	168	to	to	B-VP	TO	O	8	VMOD	O
O	O	169	176	secrete	secrete	I-VP	VB	O	2	NMOD	O
T3	B-Protein	177	188	interleukin	interleukin	B-NP	NN	B-protein	8	OBJ	B-protein
T3	I-Protein	188	189	-	-	O	HYPH	O	9	P	O
T3	I-Protein	189	190	2	2	B-NP	CD	O	9	NMOD	O
O	O	191	192	(	(	O	(	O	9	NMOD	O
T4	B-Protein	192	194	IL	IL	B-NP	NN	B-protein	17	SUB	B-protein
T4	I-Protein	194	195	-	-	B-ADJP	HYPH	I-protein	15	DEP	I-protein
T4	I-Protein	195	196	2	2	B-LST	LS	I-protein	17	VMOD	I-protein
O	O	196	197	)	)	O	)	O	15	DEP	O
O	O	198	201	has	have	B-VP	VBZ	O	12	SBAR	O
O	O	202	206	been	be	I-VP	VBN	O	17	VC	O
O	O	207	215	reported	report	I-VP	VBN	O	18	VC	O
O	O	216	218	to	to	I-VP	TO	O	21	VMOD	O
O	O	219	221	be	be	I-VP	VB	O	19	VMOD	O
O	O	222	230	variable	variable	B-ADJP	JJ	O	21	PRD	O
O	O	230	231	.	.	O	.	O	2	P	O

O	O	232	234	We	We	B-NP	PRP	O	2	SUB	O
O	O	235	243	analysed	analyse	B-VP	VBD	O	0	ROOT	O
T5	B-Protein	244	246	IL	IL	B-NP	NN	B-protein	6	NMOD	B-protein
T5	I-Protein	246	247	-	-	O	HYPH	I-protein	3	NMOD	I-protein
T5	I-Protein	247	248	2	2	B-NP	CD	I-protein	6	NMOD	I-protein
O	O	249	259	production	production	I-NP	NN	O	2	OBJ	O
O	O	260	262	in	in	B-PP	IN	O	6	NMOD	O
O	O	263	271	purified	purify	B-NP	VBN	O	13	NMOD	O
O	O	272	280	neonatal	neonatal	I-NP	JJ	B-cell_type	11	AMOD	B-cell_type
O	O	281	284	and	and	I-NP	CC	I-cell_type	11	AMOD	I-cell_type
O	O	285	290	adult	adult	I-NP	JJ	I-cell_type	13	NMOD	I-cell_type
O	O	291	292	T	T	I-NP	NN	I-cell_type	13	NMOD	I-cell_type
O	O	293	298	cells	cell	I-NP	NNS	I-cell_type	7	PMOD	I-cell_type
O	O	299	304	using	use	B-VP	VBG	O	2	VMOD	O
O	O	305	315	polyclonal	polyclonal	B-NP	JJ	O	21	NMOD	O
O	O	316	325	activator	activator	I-NP	NN	O	21	NMOD	O
O	O	326	333	phorbol	phorbol	I-NP	NN	O	21	NMOD	O
O	O	334	339	ester	ester	I-NP	NN	O	21	NMOD	O
O	O	340	341	+	+	B-VP	SYM	O	21	NMOD	O
O	O	342	349	calcium	calcium	B-NP	NN	O	21	NMOD	O
O	O	350	359	ionophore	ionophore	I-NP	NN	O	14	OBJ	O
O	O	360	361	(	(	O	(	O	26	DEP	O
O	O	361	365	PDBu	PDBu	B-NP	NN	O	25	NMOD	O
O	O	366	367	+	+	B-NP	SYM	O	25	NMOD	O
O	O	368	372	iono	iono	I-NP	NN	O	26	DEP	O
O	O	372	373	)	)	O	)	O	21	NMOD	O
O	O	374	376	or	or	O	CC	O	28	NMOD	O
T19	B-Entity	377	385	receptor	receptor	B-NP	NN	O	21	NMOD	O
O	O	385	386	-	-	O	HYPH	O	28	P	O
O	O	386	394	mediated	mediate	B-VP	VBN	O	28	NMOD	O
O	O	395	399	anti	anti	O	AFX	O	42	NMOD	O
O	O	399	400	-	-	O	HYPH	O	42	NMOD	O
T20	B-Entity	400	403	CD3	CD3	B-NP	NN	B-protein	42	NMOD	B-protein
O	O	403	404	/	/	O	SYM	O	42	P	O
O	O	404	408	anti	anti	O	AFX	O	42	NMOD	O
O	O	408	409	-	-	O	HYPH	O	42	NMOD	O
T21	B-Entity	409	412	CD3	CD3	B-NP	NN	B-protein	42	NMOD	B-protein
O	O	412	413	+	+	O	SYM	O	42	NMOD	O
O	O	414	418	anti	anti	O	AFX	O	42	NMOD	O
O	O	418	419	-	-	O	HYPH	O	42	NMOD	O
T6	B-Protein	419	423	CD28	CD28	B-NP	NN	B-protein	42	NMOD	B-protein
O	O	424	435	stimulation	stimulation	I-NP	NN	O	30	VMOD	O
O	O	435	436	.	.	O	.	O	2	P	O

O	O	437	441	PDBu	PDBu	B-NP	NN	O	3	NMOD	O
O	O	442	443	+	+	I-NP	CC	O	3	NMOD	O
O	O	444	448	iono	iono	I-NP	NN	O	4	SUB	O
O	O	449	456	induced	induce	B-VP	VBD	O	39	VMOD	O
O	O	457	464	equally	equally	B-NP	RB	O	6	AMOD	O
O	O	465	469	high	high	I-NP	JJ	O	10	NMOD	O
T7	B-Protein	470	472	IL	IL	I-NP	NN	B-protein	10	NMOD	B-protein
T7	I-Protein	472	473	-	-	B-NP	HYPH	I-protein	10	NMOD	I-protein
T7	I-Protein	473	474	2	2	I-NP	CD	I-protein	10	NMOD	I-protein
O	O	475	481	levels	level	I-NP	NNS	O	4	OBJ	O
O	O	482	484	in	in	B-PP	IN	O	4	VMOD	O
O	O	485	489	both	both	O	CC	O	13	NMOD	O
O	O	490	496	groups	group	B-NP	NNS	O	11	PMOD	O
O	O	497	500	and	and	O	CC	O	4	VMOD	O
O	O	500	501	,	,	O	,	O	4	P	O
O	O	502	506	when	when	B-ADVP	WRB	O	4	VMOD	O
O	O	507	517	stimulated	stimulate	B-VP	VBN	O	16	SBAR	O
O	O	518	522	with	with	B-PP	IN	O	17	VMOD	O
O	O	523	528	plate	plate	B-NP	NN	O	21	SUB	O
O	O	528	529	-	-	O	HYPH	O	19	P	O
O	O	529	534	bound	bind	B-VP	VBN	O	18	SBAR	O
O	O	535	539	anti	anti	B-NP	AFX	O	21	VMOD	O
O	O	539	540	-	-	I-NP	HYPH	B-protein	22	NMOD	B-protein
T22	B-Entity	540	543	CD3	CD3	I-NP	NN	I-protein	26	NMOD	I-protein
O	O	544	554	monoclonal	monoclonal	I-NP	JJ	I-protein	26	NMOD	I-protein
O	O	555	563	antibody	antibody	I-NP	NN	I-protein	23	NMOD	I-protein
O	O	564	565	(	(	O	(	O	29	DEP	O
O	O	565	568	mAb	mAb	B-NP	NN	B-protein	29	DEP	B-protein
O	O	568	569	)	)	O	)	O	26	NMOD	O
O	O	569	570	,	,	O	,	O	4	P	O
O	O	571	574	the	the	B-NP	DT	O	35	NMOD	O
T8	B-Protein	575	577	IL	IL	I-NP	NN	B-protein	35	NMOD	B-protein
T8	I-Protein	577	578	-	-	I-NP	HYPH	I-protein	35	NMOD	I-protein
T8	I-Protein	578	579	2	2	I-NP	CD	I-protein	35	NMOD	I-protein
O	O	580	589	secretion	secretion	I-NP	NN	O	39	SUB	O
O	O	590	592	by	by	B-PP	IN	O	35	NMOD	O
O	O	593	601	neonatal	neonatal	B-NP	JJ	B-cell_type	38	NMOD	B-cell_type
O	O	602	607	cells	cell	I-NP	NNS	I-cell_type	36	PMOD	I-cell_type
O	O	608	611	was	be	B-VP	VBD	O	44	VMOD	O
O	O	612	624	undetectable	undetectable	B-NP	JJ	O	39	PRD	O
O	O	625	628	and	and	I-NP	CC	O	44	VMOD	O
O	O	629	634	adult	adult	I-NP	JJ	B-cell_type	43	NMOD	B-cell_type
O	O	635	640	cells	cell	I-NP	NNS	I-cell_type	44	SUB	I-cell_type
O	O	641	649	produced	produce	B-VP	VBD	O	0	ROOT	O
O	O	650	653	low	low	B-NP	JJ	O	46	NMOD	O
O	O	654	661	amounts	amount	I-NP	NNS	O	44	OBJ	O
O	O	662	664	of	of	B-PP	IN	O	46	NMOD	O
T9	B-Protein	665	667	IL	IL	B-NP	NN	B-protein	47	PMOD	B-protein
T9	I-Protein	667	668	-	-	B-NP	HYPH	I-protein	48	NMOD	I-protein
T9	I-Protein	668	669	2	2	I-NP	CD	I-protein	48	NMOD	I-protein
O	O	670	671	(	(	O	(	O	61	DEP	O
O	O	671	675	mean	mean	B-NP	NN	O	60	NMOD	O
O	O	676	679	331	331	I-NP	CD	O	60	NMOD	O
O	O	680	681	+	+	O	SYM	O	60	NMOD	O
O	O	681	682	/	/	O	SYM	O	60	P	O
O	O	682	683	-	-	O	SYM	O	60	NMOD	O
O	O	684	686	86	86	B-NP	CD	O	60	NMOD	O
O	O	687	689	pg	pg	I-NP	NN	O	60	NMOD	O
O	O	689	690	/	/	B-NP	SYM	O	60	P	O
O	O	690	692	ml	ml	I-NP	NN	O	61	DEP	O
O	O	692	693	)	)	O	)	O	46	NMOD	O
O	O	693	694	.	.	O	.	O	44	P	O

O	O	695	698	The	The	B-NP	DT	O	2	NMOD	O
O	O	699	707	addition	addition	I-NP	NN	O	16	SUB	O
O	O	708	710	of	of	B-PP	IN	O	2	NMOD	O
O	O	711	715	anti	anti	B-NP	AFX	O	7	NMOD	O
O	O	715	716	-	-	I-NP	HYPH	B-protein	7	NMOD	B-protein
T10	B-Protein	716	720	CD28	CD28	I-NP	NN	I-protein	7	NMOD	I-protein
O	O	721	724	mAb	mAb	I-NP	NN	I-protein	3	PMOD	I-protein
O	O	725	727	to	to	B-PP	TO	O	2	NMOD	O
O	O	728	732	anti	anti	B-NP	AFX	O	14	NMOD	O
O	O	732	733	-	-	I-NP	HYPH	O	14	NMOD	O
T23	B-Entity	733	736	CD3	CD3	I-NP	NN	B-protein	14	NMOD	B-protein
O	O	736	737	-	-	I-NP	HYPH	O	14	NMOD	O
O	O	737	747	stimulated	stimulate	I-NP	VBN	B-cell_line	14	NMOD	B-cell_line
O	O	748	753	cells	cell	I-NP	NNS	I-cell_line	8	PMOD	I-cell_line
O	O	754	762	markedly	markedly	B-ADVP	RB	O	16	VMOD	O
O	O	763	772	increased	increase	B-VP	VBD	O	36	VMOD	O
T11	B-Protein	773	775	IL	IL	B-NP	NN	B-protein	20	NMOD	B-protein
T11	I-Protein	775	776	-	-	O	HYPH	I-protein	17	NMOD	I-protein
T11	I-Protein	776	777	2	2	B-NP	CD	I-protein	20	NMOD	I-protein
O	O	778	788	production	production	I-NP	NN	O	16	OBJ	O
O	O	789	791	in	in	B-PP	IN	O	20	NMOD	O
O	O	792	796	both	both	B-NP	DT	O	24	NMOD	O
O	O	797	801	cell	cell	I-NP	NN	O	24	NMOD	O
O	O	802	807	types	type	I-NP	NNS	O	21	PMOD	O
O	O	807	808	,	,	O	,	O	36	P	O
O	O	809	812	but	but	O	CC	O	36	VMOD	O
O	O	813	819	levels	level	B-NP	NNS	O	36	SUB	O
O	O	820	822	of	of	B-PP	IN	O	27	NMOD	O
T12	B-Protein	823	825	IL	IL	B-NP	NN	B-protein	30	NMOD	B-protein
T12	I-Protein	825	826	-	-	B-NP	HYPH	I-protein	28	PMOD	I-protein
T12	I-Protein	826	827	2	2	I-NP	CD	I-protein	30	NMOD	I-protein
O	O	828	830	in	in	B-PP	IN	O	27	NMOD	O
O	O	831	839	neonatal	neonatal	B-NP	JJ	B-cell_type	35	NMOD	B-cell_type
O	O	840	841	T	T	I-NP	NN	I-cell_type	35	NMOD	I-cell_type
O	O	842	847	cells	cell	I-NP	NNS	I-cell_type	32	PMOD	I-cell_type
O	O	848	856	remained	remain	B-VP	VBD	O	0	ROOT	O
O	O	857	864	clearly	clearly	B-ADJP	RB	O	36	VMOD	O
O	O	865	870	lower	low	I-ADJP	JJR	O	36	PRD	O
O	O	871	875	than	than	B-PP	IN	O	38	AMOD	O
O	O	876	881	those	those	B-NP	DT	O	39	PMOD	O
O	O	882	884	of	of	B-PP	IN	O	40	NMOD	O
O	O	885	890	adult	adult	B-NP	JJ	B-cell_type	44	NMOD	B-cell_type
O	O	891	892	T	T	I-NP	NN	I-cell_type	44	NMOD	I-cell_type
O	O	893	898	cells	cell	I-NP	NNS	I-cell_type	41	PMOD	I-cell_type
O	O	899	900	(	(	O	(	O	67	DEP	O
O	O	900	910	respective	respective	B-NP	JJ	O	48	NMOD	O
O	O	911	915	mean	mean	I-NP	JJ	O	48	NMOD	O
O	O	916	922	values	value	I-NP	NNS	O	66	NMOD	O
O	O	922	923	:	:	O	:	O	66	P	O
O	O	924	927	385	385	B-NP	CD	O	57	NMOD	O
O	O	928	929	+	+	O	SYM	O	57	NMOD	O
O	O	929	930	/	/	O	SYM	O	57	NMOD	O
O	O	930	931	-	-	O	SYM	O	57	NMOD	O
O	O	932	935	109	109	B-NP	CD	O	57	NMOD	O
O	O	936	938	pg	pg	I-NP	NN	O	57	NMOD	O
O	O	938	939	/	/	B-NP	SYM	O	57	NMOD	O
O	O	939	941	ml	ml	I-NP	NN	O	66	NMOD	O
O	O	942	945	and	and	O	CC	O	66	NMOD	O
O	O	946	950	4494	4494	B-NP	CD	O	66	NMOD	O
O	O	951	952	+	+	O	SYM	O	66	NMOD	O
O	O	952	953	/	/	O	SYM	O	66	P	O
O	O	953	954	-	-	O	SYM	O	66	NMOD	O
O	O	955	959	1199	1199	B-NP	CD	O	66	NMOD	O
O	O	960	962	pg	pg	I-NP	NN	O	66	NMOD	O
O	O	962	963	/	/	B-NP	SYM	O	66	P	O
O	O	963	965	ml	ml	I-NP	NN	O	67	DEP	O
O	O	965	966	)	)	O	)	O	36	VMOD	O
O	O	966	967	.	.	O	.	O	36	P	O

O	O	968	970	As	As	B-SBAR	IN	O	22	VMOD	O
T24	B-Entity	971	973	NF	NF	B-NP	NN	B-protein	5	NMOD	B-protein
T24	I-Entity	973	974	-	-	B-NP	HYPH	I-protein	5	NMOD	I-protein
T24	I-Entity	974	979	kappa	kappa	I-NP	NN	I-protein	5	NMOD	I-protein
T24	I-Entity	980	981	B	B	I-NP	NN	I-protein	6	SUB	I-protein
O	O	982	984	is	be	B-VP	VBZ	O	1	SBAR	O
O	O	985	986	a	a	B-NP	DT	O	10	NMOD	O
O	O	987	995	critical	critical	I-NP	JJ	O	10	NMOD	O
O	O	996	1009	transcription	transcription	I-NP	NN	B-protein	10	NMOD	B-protein
O	O	1010	1016	factor	factor	I-NP	NN	I-protein	6	PRD	I-protein
O	O	1017	1019	in	in	B-PP	IN	O	10	NMOD	O
O	O	1020	1023	the	the	B-NP	DT	O	13	NMOD	O
O	O	1024	1031	control	control	I-NP	NN	O	11	PMOD	O
O	O	1032	1034	of	of	B-PP	IN	O	13	NMOD	O
T13	B-Protein	1035	1037	IL	IL	B-NP	NN	B-protein	18	NMOD	B-protein
T13	I-Protein	1037	1038	-	-	O	HYPH	I-protein	18	NMOD	I-protein
T13	I-Protein	1038	1039	2	2	B-NP	CD	I-protein	18	NMOD	I-protein
O	O	1040	1050	expression	expression	I-NP	NN	O	14	PMOD	O
O	O	1050	1051	,	,	O	,	O	22	P	O
O	O	1052	1054	we	we	B-NP	PRP	O	22	SUB	O
O	O	1055	1059	next	next	B-ADVP	RB	O	22	VMOD	O
O	O	1060	1068	analysed	analyse	B-VP	VBD	O	62	VMOD	O
O	O	1069	1072	its	its	B-NP	PRP$	O	25	NMOD	O
O	O	1073	1080	nuclear	nuclear	I-NP	JJ	O	25	NMOD	O
O	O	1081	1094	translocation	translocation	I-NP	NN	O	22	OBJ	O
O	O	1095	1097	in	in	B-PP	IN	O	25	NMOD	O
O	O	1098	1106	neonatal	neonatal	B-NP	JJ	B-cell_type	31	NMOD	B-cell_type
O	O	1107	1110	and	and	I-NP	CC	I-cell_type	31	NMOD	I-cell_type
O	O	1111	1116	adult	adult	I-NP	JJ	I-cell_type	31	NMOD	I-cell_type
O	O	1117	1118	T	T	I-NP	NN	I-cell_type	31	NMOD	I-cell_type
O	O	1119	1124	cells	cell	I-NP	NNS	I-cell_type	26	PMOD	I-cell_type
O	O	1125	1130	using	use	B-VP	VBG	O	22	VMOD	O
O	O	1131	1134	the	the	B-NP	DT	O	37	NMOD	O
O	O	1135	1150	electrophoretic	electrophoretic	I-NP	JJ	O	37	NMOD	O
O	O	1151	1159	mobility	mobility	I-NP	NN	O	37	NMOD	O
O	O	1160	1165	shift	shift	I-NP	NN	O	37	NMOD	O
O	O	1166	1171	assay	assay	I-NP	NN	O	32	OBJ	O
O	O	1172	1175	and	and	O	CC	O	62	VMOD	O
O	O	1175	1176	,	,	O	,	O	62	P	O
O	O	1177	1184	because	because	B-SBAR	IN	O	62	VMOD	O
O	O	1185	1194	induction	induction	B-NP	NN	O	49	SUB	O
O	O	1195	1197	of	of	B-PP	IN	O	41	NMOD	O
O	O	1198	1206	reactive	reactive	B-NP	JJ	O	45	NMOD	O
O	O	1207	1213	oxygen	oxygen	I-NP	NN	O	45	NMOD	O
O	O	1214	1227	intermediates	intermediate	I-NP	NNS	O	42	PMOD	O
O	O	1228	1229	(	(	O	(	O	48	DEP	O
O	O	1229	1232	ROI	ROI	B-NP	NN	O	48	DEP	O
O	O	1232	1233	)	)	O	)	O	45	NMOD	O
O	O	1234	1236	is	be	B-VP	VBZ	O	40	SBAR	O
O	O	1237	1245	required	require	I-VP	VBN	O	49	VC	O
O	O	1246	1249	for	for	B-PP	IN	O	50	VMOD	O
O	O	1250	1253	the	the	B-NP	DT	O	53	NMOD	O
O	O	1254	1264	activation	activation	I-NP	NN	O	51	PMOD	O
O	O	1265	1267	of	of	B-PP	IN	O	53	NMOD	O
T25	B-Entity	1268	1270	NF	NF	B-NP	NN	B-protein	58	NMOD	B-protein
T25	I-Entity	1270	1271	-	-	B-NP	HYPH	I-protein	58	NMOD	I-protein
T25	I-Entity	1271	1276	kappa	kappa	I-NP	NN	I-protein	58	NMOD	I-protein
T25	I-Entity	1277	1278	B	B	I-NP	NN	I-protein	54	PMOD	I-protein
O	O	1278	1279	,	,	O	,	O	62	P	O
O	O	1280	1282	we	we	B-NP	PRP	O	62	SUB	O
O	O	1283	1287	also	also	B-ADVP	RB	O	62	VMOD	O
O	O	1288	1296	analysed	analyse	B-VP	VBD	O	0	ROOT	O
O	O	1297	1303	levels	level	B-NP	NNS	O	62	OBJ	O
O	O	1304	1306	of	of	B-PP	IN	O	63	NMOD	O
O	O	1307	1320	intracellular	intracellular	B-NP	JJ	O	66	NMOD	O
O	O	1321	1324	ROI	ROI	I-NP	NN	O	64	PMOD	O
O	O	1325	1327	in	in	B-PP	IN	O	63	NMOD	O
O	O	1328	1333	these	these	B-NP	DT	O	69	NMOD	O
O	O	1334	1339	cells	cell	I-NP	NNS	O	67	PMOD	O
O	O	1340	1345	using	use	B-VP	VBG	O	62	VMOD	O
O	O	1346	1349	the	the	B-NP	DT	O	76	NMOD	O
O	O	1350	1353	ROI	ROI	I-NP	NN	O	76	NMOD	O
O	O	1353	1354	-	-	B-NP	HYPH	O	76	P	O
O	O	1354	1362	reactive	reactive	I-NP	JJ	O	76	NMOD	O
O	O	1363	1375	fluorochrome	fluorochrome	I-NP	NN	O	76	NMOD	O
O	O	1376	1380	DCFH	DCFH	I-NP	NN	O	81	NMOD	O
O	O	1380	1381	-	-	B-NP	HYPH	O	81	NMOD	O
O	O	1381	1383	DA	DA	I-NP	NN	O	81	NMOD	O
O	O	1384	1387	and	and	I-NP	CC	O	81	NMOD	O
O	O	1388	1392	flow	flow	I-NP	NN	O	81	NMOD	O
O	O	1393	1402	cytometry	cytometry	I-NP	NN	O	70	OBJ	O
O	O	1402	1403	.	.	O	.	O	62	P	O

O	O	1404	1406	In	In	B-PP	IN	O	18	VMOD	O
O	O	1407	1415	neonatal	neonatal	B-NP	JJ	B-cell_type	4	NMOD	B-cell_type
O	O	1416	1417	T	T	I-NP	NN	I-cell_type	4	NMOD	I-cell_type
O	O	1418	1423	cells	cell	I-NP	NNS	I-cell_type	1	PMOD	I-cell_type
T26	B-Entity	1424	1426	NF	NF	I-NP	NN	B-protein	8	NMOD	B-protein
T26	I-Entity	1426	1427	-	-	B-NP	HYPH	I-protein	8	NMOD	I-protein
T26	I-Entity	1427	1432	kappa	kappa	I-NP	NN	I-protein	8	NMOD	I-protein
T26	I-Entity	1433	1434	B	B	I-NP	NN	I-protein	9	NMOD	I-protein
O	O	1435	1445	activation	activation	I-NP	NN	O	12	NMOD	O
O	O	1446	1449	and	and	O	CC	O	12	NMOD	O
O	O	1450	1453	ROI	ROI	B-NP	NNS	O	12	NMOD	O
O	O	1454	1463	formation	formation	I-NP	NN	O	18	SUB	O
O	O	1464	1469	after	after	B-PP	IN	O	12	NMOD	O
O	O	1470	1474	anti	anti	B-NP	AFX	O	17	NMOD	O
O	O	1474	1475	-	-	I-NP	HYPH	O	17	NMOD	O
T27	B-Entity	1475	1478	CD3	CD3	I-NP	NN	B-protein	17	NMOD	B-protein
O	O	1479	1490	stimulation	stimulation	I-NP	NN	O	13	PMOD	O
O	O	1491	1495	were	be	B-VP	VBD	O	51	VMOD	O
O	O	1496	1499	low	low	B-ADJP	JJ	O	18	PRD	O
O	O	1500	1508	compared	compare	B-PP	VBN	O	18	VMOD	O
O	O	1509	1513	with	with	B-PP	IN	O	20	PMOD	O
O	O	1514	1519	adult	adult	B-NP	JJ	B-cell_type	24	NMOD	B-cell_type
O	O	1520	1521	T	T	I-NP	NN	I-cell_type	24	NMOD	I-cell_type
O	O	1522	1527	cells	cell	I-NP	NNS	I-cell_type	21	PMOD	I-cell_type
O	O	1528	1531	and	and	O	CC	O	51	VMOD	O
O	O	1531	1532	,	,	O	,	O	51	P	O
O	O	1533	1541	although	although	B-SBAR	IN	O	51	VMOD	O
O	O	1542	1550	addition	addition	B-NP	NN	O	34	SUB	O
O	O	1551	1553	of	of	B-PP	IN	O	28	NMOD	O
O	O	1554	1558	anti	anti	B-NP	AFX	O	33	NMOD	O
O	O	1558	1559	-	-	I-NP	HYPH	B-protein	33	NMOD	B-protein
T14	B-Protein	1559	1563	CD28	CD28	I-NP	NN	I-protein	33	NMOD	I-protein
O	O	1564	1567	mAb	mAb	I-NP	NN	I-protein	29	PMOD	I-protein
O	O	1568	1577	increased	increase	B-VP	VBD	O	27	SBAR	O
O	O	1578	1587	induction	induction	B-NP	NN	O	43	NMOD	O
O	O	1588	1590	of	of	B-PP	IN	O	35	NMOD	O
T28	B-Entity	1591	1593	NF	NF	B-NP	NN	B-protein	40	NMOD	B-protein
T28	I-Entity	1593	1594	-	-	B-NP	HYPH	I-protein	40	NMOD	I-protein
T28	I-Entity	1594	1599	kappa	kappa	I-NP	NN	I-protein	40	NMOD	I-protein
T28	I-Entity	1600	1601	B	B	I-NP	NN	I-protein	36	PMOD	I-protein
O	O	1602	1605	and	and	O	CC	O	43	NMOD	O
O	O	1606	1609	ROI	ROI	B-NP	NN	O	43	NMOD	O
O	O	1610	1619	formation	formation	I-NP	NN	O	34	OBJ	O
O	O	1619	1620	,	,	O	,	O	51	P	O
O	O	1621	1627	levels	level	B-NP	NNS	O	51	SUB	O
O	O	1628	1635	similar	similar	B-ADJP	JJ	O	45	NMOD	O
O	O	1636	1638	to	to	B-PP	TO	O	46	AMOD	O
O	O	1639	1644	those	those	B-NP	DT	O	47	PMOD	O
O	O	1645	1647	of	of	B-PP	IN	O	48	NMOD	O
O	O	1648	1654	adults	adult	B-NP	NNS	O	49	PMOD	O
O	O	1655	1659	were	be	B-VP	VBD	O	0	ROOT	O
O	O	1660	1663	not	not	I-VP	RB	O	51	VMOD	O
O	O	1664	1672	achieved	achieve	I-VP	VBN	O	51	VC	O
O	O	1672	1673	.	.	O	.	O	51	P	O

O	O	1674	1679	After	After	B-PP	IN	O	9	VMOD	O
O	O	1680	1684	PDBu	PDBu	B-NP	NN	O	5	NMOD	O
O	O	1685	1686	+	+	I-NP	CC	O	5	NMOD	O
O	O	1687	1691	iono	iono	I-NP	NN	O	5	NMOD	O
O	O	1692	1703	stimulation	stimulation	I-NP	NN	O	1	PMOD	O
O	O	1703	1704	,	,	O	,	O	9	P	O
O	O	1705	1708	the	the	B-NP	DT	O	8	NMOD	O
O	O	1709	1714	cells	cell	I-NP	NNS	O	9	SUB	O
O	O	1715	1721	showed	show	B-VP	VBD	O	0	ROOT	O
O	O	1722	1729	similar	similar	B-NP	JJ	O	17	NMOD	O
O	O	1730	1733	ROI	ROI	I-NP	NNS	O	12	NMOD	O
O	O	1734	1743	formation	formation	I-NP	NN	O	17	NMOD	O
O	O	1744	1747	and	and	I-NP	CC	O	17	NMOD	O
T15	B-Protein	1748	1750	IL	IL	I-NP	NN	B-protein	17	NMOD	B-protein
T15	I-Protein	1750	1751	-	-	O	HYPH	I-protein	17	NMOD	I-protein
T15	I-Protein	1751	1752	2	2	B-NP	CD	I-protein	17	NMOD	I-protein
O	O	1753	1762	secretion	secretion	I-NP	NN	O	9	OBJ	O
O	O	1762	1763	.	.	O	.	O	9	P	O

O	O	1764	1767	Our	Our	B-NP	PRP$	O	2	NMOD	O
O	O	1768	1775	results	result	I-NP	NNS	O	3	SUB	O
O	O	1776	1783	suggest	suggest	B-VP	VBP	O	0	ROOT	O
O	O	1784	1788	that	that	B-SBAR	IN	O	32	DEP	O
O	O	1789	1796	reduced	reduce	B-NP	VBN	O	9	NMOD	O
T16	B-Protein	1797	1799	IL	IL	I-NP	NN	B-protein	9	NMOD	B-protein
T16	I-Protein	1799	1800	-	-	O	HYPH	I-protein	9	NMOD	I-protein
T16	I-Protein	1800	1801	2	2	B-NP	CD	I-protein	9	NMOD	I-protein
O	O	1802	1812	production	production	I-NP	NN	O	14	SUB	O
O	O	1813	1815	by	by	B-PP	IN	O	9	NMOD	O
O	O	1816	1824	neonatal	neonatal	B-NP	JJ	B-cell_type	13	NMOD	B-cell_type
O	O	1825	1826	T	T	I-NP	NN	I-cell_type	13	NMOD	I-cell_type
O	O	1827	1832	cells	cell	I-NP	NNS	I-cell_type	10	PMOD	I-cell_type
O	O	1833	1835	is	be	B-VP	VBZ	O	4	SBAR	O
O	O	1836	1844	specific	specific	B-ADJP	JJ	O	14	PRD	O
O	O	1845	1848	for	for	B-PP	IN	O	15	AMOD	O
O	O	1849	1853	anti	anti	B-NP	AFX	O	30	NMOD	O
O	O	1853	1854	-	-	I-NP	HYPH	O	30	NMOD	O
T29	B-Entity	1854	1857	CD3	CD3	I-NP	NN	B-protein	30	NMOD	B-protein
O	O	1858	1861	and	and	O	CC	O	30	NMOD	O
O	O	1862	1866	anti	anti	O	AFX	O	30	NMOD	O
O	O	1866	1867	-	-	O	HYPH	O	30	NMOD	O
T30	B-Entity	1867	1870	CD3	CD3	B-NP	NN	B-protein	30	NMOD	B-protein
O	O	1870	1871	+	+	O	SYM	O	30	NMOD	O
O	O	1872	1876	anti	anti	O	AFX	O	30	NMOD	O
O	O	1876	1877	-	-	B-NP	HYPH	O	30	NMOD	O
T17	B-Protein	1877	1881	CD28	CD28	I-NP	NN	B-protein	30	NMOD	B-protein
O	O	1881	1882	-	-	O	HYPH	O	30	NMOD	O
O	O	1882	1890	mediated	mediate	B-NP	VBN	O	30	NMOD	O
O	O	1891	1902	stimulation	stimulation	I-NP	NN	O	16	PMOD	O
O	O	1903	1906	and	and	O	CC	O	32	DEP	O
O	O	1907	1911	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	1912	1917	these	these	B-NP	DT	O	34	NMOD	O
O	O	1918	1928	activators	activator	I-NP	NNS	O	35	SUB	O
O	O	1929	1935	cannot	cannot	B-VP	MD	O	32	SBAR	O
O	O	1936	1947	effectively	effectively	I-VP	RB	O	37	VMOD	O
O	O	1948	1956	activate	activate	I-VP	VB	O	35	VC	O
O	O	1957	1960	the	the	B-NP	DT	O	39	NMOD	O
O	O	1961	1964	ROI	ROI	I-NP	NN	O	46	NMOD	O
O	O	1964	1965	-	-	B-NP	HYPH	O	46	NMOD	O
T31	B-Entity	1965	1967	NF	NF	I-NP	NN	B-protein	46	NMOD	B-protein
T31	I-Entity	1967	1968	-	-	B-NP	HYPH	I-protein	46	NMOD	I-protein
T31	I-Entity	1968	1973	kappa	kappa	I-NP	NN	I-protein	46	NMOD	I-protein
T31	I-Entity	1974	1975	B	B	I-NP	NN	I-protein	46	NMOD	I-protein
O	O	1976	1986	signalling	signalling	I-NP	NN	O	46	NMOD	O
O	O	1987	1994	pathway	pathway	I-NP	NN	O	37	OBJ	O
O	O	1995	1997	in	in	B-PP	IN	O	46	NMOD	O
O	O	1998	2006	neonatal	neonatal	B-NP	JJ	B-cell_type	50	NMOD	B-cell_type
O	O	2007	2008	T	T	I-NP	NN	I-cell_type	50	NMOD	I-cell_type
O	O	2009	2014	cells	cell	I-NP	NNS	I-cell_type	47	PMOD	I-cell_type
O	O	2014	2015	.	.	O	.	O	3	P	O
